OPKO Health Reports Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- Wall St set for higher open as AI stocks rise, oil slides
Cantor Fitzgerald Maintains Bullish View on Opko Health (OPK) Following Beat
August 8, 2018 6:45 AM EDTCantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $20 price target on Opko Health (NASDAQ: OPK) following its Q2 EPS beat.
Chen commented, "We continue to think that the long-term sales and earnings potential of OPK's business is underappreciated and that upward... More
